Perma-Fix Environmental Services, Inc. (NASDAQ:
PESI) (the “Company”) today announced financial results
and provided a business update for the fourth quarter and full year
ended December 31, 2021.
Mark Duff, President and CEO of the Company,
commented, “Despite the challenges faced in 2021, we achieved a
number of important milestones. Specifically, we were awarded
strategic and high-profile projects within our Services Segment
resulting in over $66 million in project backlog, which provides us
a solid foundation for 2022 as these projects ramp up. We are
encouraged by the approved federal budgets that will directly
support our portfolio of Indefinite Delivery/Indefinite Quantity
(IDIQ) contracts or multi-award task order contracts (MATOCs). In
turn, this is expected to result in the release of a significant
backlog of task orders over the next few quarters. Within our
Treatment Segment, although we continued to experience weakness due
to the pandemic, revenues increased 56.8% for the fourth quarter of
2021 compared to the same period in 2020, and we have seen further
improvement heading into the new year.”
“During 2021 we enhanced our capabilities and
personnel, while maintaining our workforce despite industry wide
labor shortages, which we believe will enable us to gear up quickly
as we actively pursue larger procurements. We were also successful
in completing facility upgrades and technology deployments to
support expanded revenue streams within our Treatment Segment.”
“Looking ahead to 2022, we remain hopeful the
impacts of the pandemic are largely behind us and we believe we are
well positioned for the balance of the year. Although January still
experienced some of the COVID-related impact, we are seeing
improvement in our project backlog with increasing waste treatment
through March, along with successful mobilization of all our major
services projects. We are in the early phases of defining the
opportunities associated with the recently approved 2022 federal
spending bill, which allocates $900 million of incremental funding
within U.S Department of Energy’s (DOE) Office of Environmental
Management, including $7 million for low level waste off-site
disposition at Hanford to support the Test Bed Initiative program.
This budget increase, along with additional potential carryover
funding from 2021 provides us the opportunities needed to support
increased waste treatment and new projects this year. Overall, we
remain encouraged by the outlook for the business, with improved
visibility, which we believe will allow us to restore the momentum
we had prior to the pandemic.”
COVID-19The Company continues
to proactively update its ongoing business operations and safety
plans, which we believe will mitigate any potential impact of
COVID-19. However, as the situations surrounding COVID-19 remain
fluid, the full impact and extent of the pandemic on the Company’s
financial results cannot be estimated with any degree of
certainty.
Financial Results
Fourth-Quarter 2021 ResultsRevenue for the
fourth quarter of 2021 was $17.1 million versus $28.3 million for
the same period last year. Revenue from the Services Segment
decreased by $14.4 million to $8.2 million from $22.6 million for
the same period in 2020. Although our Services Segment was awarded
a number of new contracts since the end of the second quarter of
2021, work under certain of these new awards was temporarily
curtailed/delayed due to customer administrative delay and/or
COVID-19 impact experienced by the customer. Revenue for the
Treatment Segment increased approximately $3.2 million to $8.9
million in the fourth quarter of 2021 from $5.7 million for the
corresponding period of 2020. Although Treatment Segment revenue
has not returned to pre-pandemic level, our Treatment Segment has
begun to see a gradual return in waste receipts from certain
customers who have delayed waste shipment due to impact of
COVID-19.
Gross profit for the fourth quarter of 2021 was
$1.3 million and $3.2 million for the fourth quarter of 2020.
Operating loss for the fourth quarter of 2021
was approximately $2.2 million versus operating income of $188,000
for the fourth quarter of 2020. Loss from continuing operations for
the fourth quarter of 2021 was approximately $2.4 million as
compared to income from continuing operations of $100,000 for the
corresponding period of 2020. Loss from continuing operations for
the fourth quarter of 2021 included a non-cash loss of
approximately $1.1 million resulting from the sale of our Polish
majority-owned subsidiary, Perma-Fix Medical S.A. During the fourth
quarter of 2021, the Company made the strategic decision to cease
all research and development activities under its Medical Segment.
Loss per share (basic) attributable to common stockholders was
$0.19 for the fourth quarter of 2021 as compared to income per
share (basic) of $0.00 for the corresponding period of 2020.
2021 Financial ResultsRevenue in 2021 was $72.2
million versus $105.4 million in 2020. The revenue decrease was
entirely within our Services Segment where revenue decreased by
approximately $36.1 million to $39.2 million in 2021 from $75.3
million in 2020. Services Segment revenue was negatively impacted
by delays in procurement action and contract awards from the
continued impact of COVID-19 which was further exacerbated by the
completion of a large project in the second quarter of 2021 and the
near completion of a certain other project. Additionally, although
the Services Segment was awarded a number of new projects starting
in the second half of 2021, work under certain of these new awards
was temporarily curtail/delays due to customer administrative delay
and/or COVID-19 impact experienced by the customer. Revenue for the
Treatment Segment increased approximately $2.9 million to $33.0
million in 2021 from $30.1 million in 2020. Treatment Segment
revenue for 2021 included revenue recognized in the amount of
approximately $1.3 million from a request for equitable adjustment
(“REA”) under a certain contract.
Gross profit in 2021 was $6.8 million and $15.9
million in 2020.
Operating loss in 2021 was $6.8 million versus
operating income of $3.3 million in 2020. Income from continuing
operations in 2021 was approximately $1.1 million as compared to
income from continuing operations of $3.1 million in 2020. Income
from continuing operations for 2021 included a “Gain on
extinguishment of debt” recorded in the amount of approximately
$5.4 million resulting from the Paycheck Protection Program (“PPP”)
Loan that was forgiven by the U.S. Small Business Administration
effective June 2021 and a non-cash “Loss from deconsolidation of
subsidiary” recorded in the amount of approximately $1.1 million
resulting from the sale of our Polish majority-owned subsidiary as
discussed above. Additionally, income from continuing operations
for 2021 included a tax benefit recorded in the amount of
approximately $2.4 million resulting from the release of valuation
allowance on the Company’s beginning of year deferred tax assets
primarily related to U.S. Federal income taxes.
Net income attributable to common stockholders
in 2021 was $835,000 as compared to net income attributable to
common stockholders of $2.9 million in 2020. Income per share
(basic) attributable to common stockholders was $0.07 in 2021 as
compared to income per share (basic) of $0.24 in 2020.
The Company’s Adjusted EBITDA at December 31,
2021 was approximately ($4.8) million from continuing operations as
compared to approximately $5.4 million for the corresponding period
of 2020. The Company defines EBITDA as earnings before interest,
taxes, depreciation and amortization. Adjusted EBITDA is defined as
EBITDA before research and development costs related to the Medical
Isotope project, (gain) loss on extinguishment of debt and loss on
deconsolidation of subsidiary. Both EBITDA and Adjusted EBITDA are
not measures of performance calculated in accordance with
Accounting Principles Generally Accepted in the United States of
America (“GAAP”), and should not be considered in isolation of, or
as a substitute for, earnings as an indicator of operating
performance or cash flows from operating activities as a measure of
liquidity. The Company believes the presentation of EBITDA and
Adjusted EBITDA is relevant and useful by enhancing the readers’
ability to understand the Company’s operating performance. The
Company’s management utilizes EBITDA and Adjusted EBITDA as a means
to measure performance. The Company’s measurements of EBITDA and
Adjusted EBITDA may not be comparable to similar titled measures
reported by other companies. The table below reconciles EBITDA and
Adjusted EBITDA, both non-GAAP measures, to GAAP numbers for income
from continuing operations for the three and twelve months ended
December 31, 2021 and 2020.
|
|
Quarter Ended |
|
Twelve Months Ended |
|
|
December 31, |
|
December 31, |
|
|
(Unaudited) |
|
(Unaudited) |
(In thousands) |
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
(Loss) income from continuing operations |
|
$ |
(2,372 |
) |
|
$ |
100 |
|
|
$ |
1,092 |
|
|
$ |
3,149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation & amortization |
|
|
479 |
|
|
|
408 |
|
|
|
1,687 |
|
|
|
1,596 |
|
Interest income |
|
|
(3 |
) |
|
|
(28 |
) |
|
|
(26 |
) |
|
|
(140 |
) |
Interest expense |
|
|
38 |
|
|
|
92 |
|
|
|
247 |
|
|
|
398 |
|
Interest expense - financing fees |
|
|
13 |
|
|
|
107 |
|
|
|
41 |
|
|
|
294 |
|
Income tax benefit |
|
|
(1,050 |
) |
|
|
(61 |
) |
|
|
(3,890 |
) |
|
|
(189 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA |
|
|
(2,895 |
) |
|
|
618 |
|
|
|
(849 |
) |
|
|
5,108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development costs related to |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
medical Isotope project |
|
|
102 |
|
|
|
91 |
|
|
|
414 |
|
|
|
311 |
|
(Gain) loss on extinguishment of debt |
|
|
— |
|
|
|
— |
|
|
|
(5,381 |
) |
|
|
27 |
|
Loss on deconsolidation of subsidiary |
|
|
1,062 |
|
|
|
— |
|
|
|
1,062 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
$ |
(1,731 |
) |
|
$ |
709 |
|
|
$ |
(4,754 |
) |
|
$ |
5,446 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The tables below present certain financial
information for the business segments, which exclude allocation of
corporate expenses:
|
|
Three Months Ended |
|
Twelve Months Ended |
|
|
December 31, 2021 |
|
December 31, 2021 |
|
|
(Unaudited) |
|
(Audited) |
(In thousands) |
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
Net revenues |
|
$ |
8,899 |
|
$ |
8,217 |
|
$ |
— |
|
|
$ |
32,992 |
|
$ |
39,199 |
|
$ |
— |
|
Gross profit (negative gross profit) |
|
|
1,874 |
|
|
(596 |
) |
|
— |
|
|
|
6,718 |
|
|
106 |
|
|
— |
|
Segment profit (loss) |
|
|
751 |
|
|
(350 |
) |
|
(1,190 |
) |
|
|
2,433 |
|
|
(2,082 |
) |
|
(1,502 |
) |
|
|
Three Months Ended |
|
Twelve Months Ended |
|
|
December 31, 2020 |
|
December 31, 2020 |
|
|
(Unaudited) |
|
(Unaudited) |
(In thousands) |
|
|
Treatment |
|
|
|
Services |
|
|
Medical |
|
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
Net revenues |
|
$ |
5,675 |
|
|
$ |
22,672 |
|
$ |
— |
|
|
$ |
30,143 |
|
$ |
75,283 |
|
$ |
— |
|
(Negative gross profit) gross profit |
|
|
(42 |
) |
|
|
3,235 |
|
|
— |
|
|
|
5,491 |
|
|
10,402 |
|
|
— |
|
Segment (loss) profit |
|
|
(983 |
) |
|
|
2,660 |
|
|
(91 |
) |
|
|
1,758 |
|
|
7,820 |
|
|
(311 |
) |
Financial Covenant and Internal Control
over Financial ReportingThe Company failed to meet its
fixed charge coverage ratio (FCCR) requirement for the fourth
quarter of 2021 pursuant to its loan agreement. However, this
non-compliance was waived by the Company’s lender. Additionally,
the Company’s management and CEO and CFO concluded that there was a
material weakness in its internal control over financial reporting
as of December 31, 2021 due to the existence of a material weakness
in which certain revenue contracts that contained nonstandard terms
and conditions were not appropriately evaluated in accordance with
Accounting Standards Codification (ASC) 606, “Revenue from
Contracts with Customers.” This material weakness did not result in
revisions to any previously filed financial statements. The Company
is in the process of developing a plan to remediate this material
weakness.
Form 10-K FilingOur Form 10-K
for 2021 may be filed late due, in part, to additional time
required to finalize the assessment of our internal controls over
financial reporting and for examination by our independent
registered public accounting firm. If this is the case, we
anticipate that our 2021 Form 10-K may be filed within the next few
days.
Conference Call Perma-Fix will
host a conference call at 11:00 a.m. ET on Thursday, March 31,
2022. The call will be available in the investors section of the
Company’s website at https://ir.perma-fix.com/conference-calls, or
by calling 888-506-0062 for U.S. callers or +1 973-528-0011 for
international callers, and by entering access code: 524813. The
conference call will be led by Mark J. Duff, Chief Executive
Officer, Dr. Louis F. Centofanti, Executive Vice President of
Strategic Initiatives, and Ben Naccarato, Executive Vice President
and Chief Financial Officer of Perma-Fix Environmental Services,
Inc.
A webcast will also be archived on the Company’s
website and a telephone replay of the call will be available
approximately one hour following the call, through Thursday, April
7, 2022 and can be accessed by dialing 877-481-4010 for U.S.
callers or +1 919-882-2331 for international callers and entering
access code: 44975.
About Perma-Fix Environmental
ServicesPerma-Fix Environmental Services, Inc. is a
nuclear services company and leading provider of nuclear and mixed
waste management services. The Company's nuclear waste services
include management and treatment of radioactive and mixed waste for
hospitals, research labs and institutions, federal agencies,
including the DOE, the U.S Department of Defense (DOD), and the
commercial nuclear industry. The Company’s nuclear services group
provides project management, waste management, environmental
restoration, decontamination and decommissioning, new build
construction, and radiological protection, safety and industrial
hygiene capability to our clients. The Company operates four
nuclear waste treatment facilities and provides nuclear services at
DOE, DOD, and commercial facilities, nationwide.
Please visit us at http://www.perma-fix.com.
This press release contains “forward-looking
statements” which are based largely on the Company's expectations
and are subject to various business risks and uncertainties,
certain of which are beyond the Company's control. Forward-looking
statements generally are identifiable by use of the words such as
“believe”, “expects”, “intends”, “anticipate”, “plans to”,
“estimates”, “projects”, and similar expressions. Forward-looking
statements include, but are not limited to: project ramp up; COVID
related impact; approved federal budget support of IDIQ or MATOC
contracts; release of a significant backlog of task orders;
improvement heading into the new year; gear up quickly; well
positioned for 2022; increased waste treatment; remediation of
material weakness; filing of our 2021 Form 10-K; and new projects
in 2022; and outlook for business. These forward-looking statements
are intended to qualify for the safe harbors from liability
established by the Private Securities Litigation Reform Act of
1995. While the Company believes the expectations reflected in this
news release are reasonable, it can give no assurance such
expectations will prove to be correct. There are a variety of
factors which could cause future outcomes to differ materially from
those described in this release, including, without limitation,
future economic conditions; industry conditions; competitive
pressures; our ability to apply and market our new technologies;
the government or such other party to a contract granted to us
fails to abide by or comply with the contract or to deliver waste
as anticipated under the contract; inability to win bid projects;
Congress fails to provides continuing funding for the DOD’s and
DOE’s remediation projects; inability to obtain new foreign and
domestic remediation contracts; inability to meet financial
covenants; impact of the COVID-19; and the “Risk Factors” discussed
in, and the additional factors referred to under "Special Note
Regarding Forward-Looking Statements" of, our 2021 Form 10-K. The
Company makes no commitment to disclose any revisions to
forward-looking statements, or any facts, events or circumstances
after the date hereof that bear upon forward-looking
statements.
FINANCIAL TABLES FOLLOW
Contacts:David K. Waldman-US
Investor RelationsCrescendo Communications, LLC (212) 671-1021
Herbert Strauss-European Investor Relationsherbert@eu-ir.com+43
316 296 316
PERMA-FIX ENVIRONMENTAL SERVICES,
INC.CONSOLIDATED STATEMENTS OF
OPERATIONS
|
|
Three Months Ended |
|
Twelve Months Ended |
|
|
December 31, |
|
December 31, |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
(Amounts in Thousands, Except for Per Share Amounts) |
|
(Unaudited) |
|
|
|
|
|
(Unaudited) |
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenues |
$ |
17,116 |
|
$ |
28,347 |
|
$ |
72,191 |
|
$ |
105,426 |
|
Cost of goods sold |
|
15,838 |
|
|
25,154 |
|
|
65,367 |
|
|
89,533 |
|
Gross profit |
|
1,278 |
|
|
3,193 |
|
|
6,824 |
|
|
15,893 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
3,295 |
|
|
2,839 |
|
|
12,845 |
|
|
11,774 |
|
Research and development |
|
208 |
|
|
164 |
|
|
746 |
|
|
762 |
|
Loss on disposal of property and equipment |
|
1 |
|
|
2 |
|
|
2 |
|
|
29 |
|
(Loss) income from operations |
|
(2,226 |
) |
|
188 |
|
|
(6,769 |
) |
|
3,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
3 |
|
|
28 |
|
|
26 |
|
|
140 |
|
Interest expense |
|
(38 |
) |
|
(92 |
) |
|
(247 |
) |
|
(398 |
) |
Interest expense-financing fees |
|
(13 |
) |
|
(107 |
) |
|
(41 |
) |
|
(294 |
) |
Other |
|
(86 |
) |
|
22 |
|
|
(86 |
) |
|
211 |
|
Gain (loss) on debt extinguishment of debt |
|
— |
|
|
— |
|
|
5,381 |
|
|
(27 |
) |
Loss on deconsolidation of subsidiary |
|
(1,062 |
) |
|
— |
|
|
(1,062 |
) |
|
— |
|
(Loss) income from continuing operations before taxes |
|
(3,422 |
) |
|
39 |
|
|
(2,798 |
) |
|
2,960 |
|
Income tax benefit |
|
(1,050 |
) |
|
(61 |
) |
|
(3,890 |
) |
|
(189 |
) |
(Loss) income from continuing operations, net of taxes |
|
(2,372 |
) |
|
100 |
|
|
1,092 |
|
|
3,149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, net of taxes |
|
(137 |
) |
|
(146 |
) |
|
(421 |
) |
|
(412 |
) |
Net (loss) income |
|
(2,509 |
) |
|
(46 |
) |
|
671 |
|
|
2,737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to non-controlling interest |
|
(41 |
) |
|
(36 |
) |
|
(164 |
) |
|
(123 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income attributable to Perma-Fix Environmental |
|
|
|
|
|
|
|
|
|
|
|
|
Services, Inc. common stockholders |
$ |
(2,468 |
) |
$ |
(10 |
) |
$ |
835 |
|
$ |
2,860 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per common share attributable to |
|
|
|
|
|
|
|
|
|
|
|
|
Perma-Fix Environmental Services, Inc. stockholders - basic: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
$ |
(.18 |
) |
$ |
.01 |
|
$ |
.10 |
|
$ |
.27 |
|
Discontinued operations |
|
(.01 |
) |
|
(.01 |
) |
|
(.03 |
) |
|
(.03 |
) |
Net (loss) income per common share |
$ |
(.19 |
) |
$ |
— |
|
$ |
.07 |
|
$ |
.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per common share attributable to |
|
|
|
|
|
|
|
|
|
|
|
|
Perma-Fix Environmental Services, Inc. stockholders - diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
$ |
(.18 |
) |
$ |
.01 |
|
$ |
.10 |
|
$ |
.26 |
|
Discontinued operations |
|
(.01 |
) |
|
(.01 |
) |
|
(.03 |
) |
|
(.03 |
) |
Net (loss) income per common share |
$ |
(.19 |
) |
$ |
— |
|
$ |
.07 |
|
$ |
.23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common shares used in computing |
|
|
|
|
|
|
|
|
|
|
|
|
net (loss) income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
13,179 |
|
|
12,154 |
|
|
12,433 |
|
|
12,139 |
|
Diluted |
|
13,179 |
|
|
12,370 |
|
|
12,673 |
|
|
12,347 |
|
PERMA-FIX ENVIRONMENTAL SERVICES,
INC.CONDENSED CONSOLIDATED BALANCE
SHEETS
|
|
|
December 31, |
|
|
|
December 31, |
|
|
|
|
2021 |
|
|
|
2020 |
|
(Amounts in Thousands, Except for Share and Per Share Amounts) |
|
|
(Unaudited) |
|
|
|
(Audited) |
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
4,440 |
|
|
$ |
7,924 |
|
Account receivable, net of allowance for doubtful |
|
|
|
|
|
|
|
|
accounts of $85 and $404, respectively |
|
|
11,372 |
|
|
|
9,659 |
|
Unbilled receivables |
|
|
8,995 |
|
|
|
14,453 |
|
Other current assets |
|
|
5,152 |
|
|
|
4,577 |
|
Assets of discontinued operations included in current assets |
|
|
15 |
|
|
|
22 |
|
Total current assets |
|
|
29,974 |
|
|
|
36,635 |
|
|
|
|
|
|
|
|
|
|
Net property and equipment |
|
|
18,609 |
|
|
|
17,783 |
|
Property and equipment of discontinued operations |
|
|
81 |
|
|
|
81 |
|
|
|
|
|
|
|
|
|
|
Operating lease right-of-use assets |
|
|
2,460 |
|
|
|
2,287 |
|
|
|
|
|
|
|
|
|
|
Intangibles and other assets |
|
|
26,177 |
|
|
|
22,133 |
|
Other assets related to discontinued operations |
|
|
— |
|
|
|
— |
|
Total assets |
|
$ |
77,301 |
|
|
$ |
78,919 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
$ |
25,408 |
|
|
$ |
32,065 |
|
Current liabilities related to discontinued operations |
|
|
506 |
|
|
|
898 |
|
Total current liabilities |
|
|
25,914 |
|
|
|
32,963 |
|
|
|
|
|
|
|
|
|
|
Long-term liabilities |
|
|
10,126 |
|
|
|
13,253 |
|
Long-term liabilities related to discontinued operations |
|
|
677 |
|
|
|
252 |
|
Total liabilities |
|
|
36,717 |
|
|
|
46,468 |
|
Commitments and Contingencies |
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred Stock, $.001 par value; 2,000,000 shares authorized, |
|
|
|
|
|
|
|
|
no shares issued and outstanding |
|
|
— |
|
|
|
— |
|
Common Stock, $.001 par value; 30,000,000 shares authorized, |
|
|
|
|
|
|
|
|
13,222,552 and 12,161,539 shares issued, respectively; |
|
|
|
|
|
|
|
|
13,214,910 and 12,153,897 shares outstanding, respectively |
|
|
13 |
|
|
|
12 |
|
Additional paid-in capital |
|
|
114,307 |
|
|
|
108,931 |
|
Accumulated deficit |
|
|
(73,620 |
) |
|
|
(74,455 |
) |
Accumulated other comprehensive loss |
|
|
(28 |
) |
|
|
(207 |
) |
Less Common Stock held in treasury, at cost: 7,642 shares |
|
|
(88 |
) |
|
|
(88 |
) |
Total Perma-Fix Environmental Services, Inc. stockholders'
equity |
|
|
40,584 |
|
|
|
34,193 |
|
Non-controlling interest in subsidiary |
|
|
— |
|
|
|
(1,742 |
) |
Total stockholders' equity |
|
|
40,584 |
|
|
|
32,451 |
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity |
|
$ |
77,301 |
|
|
$ |
78,919 |
|
|
|
|
|
|
|
|
|
|
PermaFix Environmental S... (NASDAQ:PESI)
Historical Stock Chart
From Jun 2024 to Jul 2024
PermaFix Environmental S... (NASDAQ:PESI)
Historical Stock Chart
From Jul 2023 to Jul 2024